The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Axonics devices are implanted to help control incontinence and can last as long as 17 to 24 years or more Axonics Inc. (Nasdaq: AXNX), an Irvine-based medical device maker of products to treat ...

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...

Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an ...

I am retired from being a CEO and don’t plan on starting a newco—I am focused on board service and helping companies access ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology. April 4, 2024 FTC seeks more ...

The Federal Trade Commission (FTC) is taking a closer look at Boston Scientific’s $3.7 billion proposal to acquire neuromodulation developer Axonics, a move that could push back the closing of the ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics, Inc. after entering into a purchase agreement in January. Axonics, a publicly traded ...

Even patent judges sometimes make mistakes. That is the oversimplified takeaway from a patent dispute between Axonics and Medtronic that has been anything but simple. The two companies have been ...

It’s finally over. Medtronic and Boston Scientific’s Axonics longstanding patent battle is finished. The companies settled the legal spat over patent infringements related to sacral neuromodulation ...

Weighted-average shares used to compute basic and diluted net loss per share ...